Sciele Pharma Submits New Drug Application To FDA For Glycopyrrolate Oral Solution, A Treatment For Chronic Drooling In Pediatric Patients
Links shared publicly online about this topic.
- 1,713total visits
Sciele Pharma Submits New Drug Application To FDA For Glycopyrrolate Oral Solution, A Treatment For Chronic Drooling In Pediatric Patients
Sciele Pharma, Inc., a Shionogi company, announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to tr
View full resource at medicalnewstoday.com
Tags: Drug, Pharma, Children's Health, FDA, Shionogi
Most Recently Shared on September 29, 2009 at 4:53 pm By:
Sciele Pharma Submits New Drug Application To FDA For Glycopyrrolate Oral Solution, A Treatment For Chronic Dro.. http://tinyurl.com/y8llzwr
Also Shared By:
Advertisement
MNT Neurology News
@mnt_neurology
Sciele Pharma Submits New Drug Application To FDA For Glycopyrrolate Oral Solution, A Treatment For Chronic Dro.. http://tinyurl.com/y8llzwr
1 year ago...